{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:44:11Z","timestamp":1779309851387,"version":"3.51.4"},"reference-count":17,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute (NCI);","doi-asserted-by":"crossref","award":["U10CA180886, U10CA180999, U10CA98543"],"award-info":[{"award-number":["U10CA180886, U10CA180999, U10CA98543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"The National Cancer Institute (NCI)","doi-asserted-by":"crossref","award":["U10CA180886, U10CA180999, U10CA98543"],"award-info":[{"award-number":["U10CA180886, U10CA180999, U10CA98543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1002\/pbc.25837","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T17:18:50Z","timestamp":1447867130000},"page":"493-498","source":"Crossref","is-referenced-by-count":26,"title":["Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group"],"prefix":"10.1002","volume":"63","author":[{"given":"Leo","family":"Mascarenhas","sequence":"first","affiliation":[{"name":"The Saban Research Institute; Children's Hospital Los Angeles; California"},{"name":"Division of Hematology; Oncology; and Blood and Marrow Transplantation; Department of Pediatrics; Keck School of Medicine; University of Southern California; Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy L.","family":"Felgenhauer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics- Hematology and Oncology; Providence Sacred Heart Medical Center and Children's Hospital; Spokane Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mason C.","family":"Bond","sequence":"additional","affiliation":[{"name":"Department of Pediratics- Hematology and Oncology; British Columbia Children's Hospital; Vancouver British Columbia Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doojduen","family":"Villaluna","sequence":"additional","affiliation":[{"name":"Statistics and Data Center; Children's Oncology Group; Monrovia California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Dominic","family":"Femino","sequence":"additional","affiliation":[{"name":"Department of Surgery- Orthopaedics; City of Hope National Medical Center; Duarte California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia N.","family":"Laack","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Mayo Clinic; Rochester Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Department of Pathology; Children's Hospital of Pittsburgh of UPMC; Pittsburgh Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Radiology; Children's Hospital of Philadelphia; University of Pennsylvania School of Medicine; Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Womer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics- Oncology; Children's Hospital of Philadelphia; University of Pennsylvania School of Medicine; Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Gorlick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics- Hematology and Oncology; The Children's Hospital at Montefiore; The Albert Einstein College of Medicine of Yeshiva University; Bronx New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Krailo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics- Hematology and Oncology; Department of Preventive Medicine; Keck School of Medicine; University of Southern California; Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neyssa","family":"Marina","sequence":"additional","affiliation":[{"name":"Lucille Packard Children's Hospital; Stanford University School of Medicine; Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"issue":"Suppl 3","key":"10.1002\/pbc.25837-BIB0001|pbc25837-cit-0001","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0959-8049(11)70206-4","article-title":"Ewing sarcoma treatment","volume":"47","author":"J\u00fcrgens","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1002\/pbc.25837-BIB0002|pbc25837-cit-0002","first-page":"255","article-title":"Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: An intergroup study","volume":"56","author":"Nesbit","year":"1981","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1002\/pbc.25837-BIB0003|pbc25837-cit-0003","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.25837-BIB0004|pbc25837-cit-0004","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2008.19.1478","article-title":"Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study","volume":"27","author":"Granowetter","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0005|pbc25837-cit-0005","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0006|pbc25837-cit-0006","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.2005.02.1717","article-title":"Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group\/Children's Cancer Group Phase II Study 9457-A report from the Children's Oncology Group","volume":"24","author":"Bernstein","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0007|pbc25837-cit-0007","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/pbc.20719","article-title":"Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors","volume":"47","author":"Hunold","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25837-BIB0008|pbc25837-cit-0008","first-page":"3617","article-title":"Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts","volume":"5","author":"Thompson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.25837-BIB0009|pbc25837-cit-0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1200\/JCO.2001.19.1.213","article-title":"Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study","volume":"19","author":"Pappo","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0010|pbc25837-cit-0010","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2005.01.9497","article-title":"Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"24","author":"Lager","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0011|pbc25837-cit-0011","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","article-title":"A simple estimate of glomerular filtration rate in adolescent boys","volume":"106","author":"Schwartz","year":"1985","journal-title":"J Pediatr"},{"key":"10.1002\/pbc.25837-BIB0012|pbc25837-cit-0012","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1200\/JCO.1996.14.3.901","article-title":"Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy","volume":"14","author":"Wexler","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0013|pbc25837-cit-0013","volume-title":"The theory of rank tests","year":"1967"},{"key":"10.1002\/pbc.25837-BIB0014|pbc25837-cit-0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1002\/pbc.25837-BIB0015|pbc25837-cit-0015","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1200\/JCO.2013.54.4833","article-title":"Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: Results of the randomized noninferiority Euro-EWING99-R1 trial","volume":"32","author":"Deley","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25837-BIB0016|pbc25837-cit-0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pbc.20820","article-title":"Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial","volume":"47","author":"Juergens","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25837-BIB0017|pbc25837-cit-0017","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25837","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.25837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T10:24:27Z","timestamp":1625394267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25837"}},"subtitle":["Interval Compression With VTc in Ewing Sarcoma"],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25837","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}